Zobrazeno 1 - 10
of 55
pro vyhledávání: '"A. Alqaid"'
Publikováno v:
Southwest Respiratory and Critical Care Chronicles, Vol 3, Iss 11, Pp 35-39 (2015)
Emergence of multi-drug resistant microorganisms such as pan-resistant Pseudomonas aeruginosa has recently created a therapeutic challenge in ICU patients worldwide. New antipseudomonal antibiotics, like ceftolozane/tazobactam have been developed to
Externí odkaz:
https://doaj.org/article/d045abcf83a14495b83b169569b2e582
Autor:
Doukky, Rami *, Rangel, Maria Octavia, Wassouf, Marwan, Dick, Rizcallah, Alqaid, Ammar, Morales Demori, Raysa
Publikováno v:
In Journal of Nuclear Cardiology April 2013 20(2):205-213
Autor:
Santanu Dasgupta, Julie V. Philley, Varsha Taskar, David E. Griffith, James G. Fox, Megan S. Devine, Foram Thakkar, Anbarasu Kannan, Hernaina Bains, Jeana L. Benwill, Richard J. Wallace, Barbara A. Brown-Elliott, Ammar Alqaid, Sudeep Gupta
Publikováno v:
Oncotarget
// Julie V. Philley 1 , Anbarasu Kannan 2 , David E. Griffith 1 , Megan S. Devine 1 , Jeana L. Benwill 1 , Richard J. Wallace, Jr. 1, 3 , Barbara A. Brown-Elliott 3 , Foram Thakkar 1 , Varsha Taskar 1 , James G. Fox 1 , Ammar Alqaid 1 , Hernaina Bain
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98128631b0d0db2f1ba73761b5f5e3e4
https://doi.org/10.18632/oncotarget.14964
https://doi.org/10.18632/oncotarget.14964
Publikováno v:
Chest. 158:A1403-A1404
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04d98b7b6eb5c7884569965536837c5c
https://doi.org/10.1016/j.chest.2020.08.1270
https://doi.org/10.1016/j.chest.2020.08.1270
Autor:
C.E. Sotelo, A. Alqaid
Publikováno v:
B40. AUTOIMMUNE LUNG DISEASE CASE REPORTS.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7e62978ece8380741ae640c534049a77
https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3090
https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3090
Publikováno v:
Journal of Bronchology & Interventional Pulmonology; Oct2021, Vol. 28 Issue 4, pe62-e65, 4p
Autor:
Rishi Arora, Uzair Ghori, Aditya Sithamraju, Robert Holladay, Allen Elster, Ammar Alqaid, Paul B. Fisher, David Chambers
Publikováno v:
Chest. 158:A2658
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::59bcc3e7cdcd1b296032633357b7ad01
https://doi.org/10.1016/j.chest.2020.09.273
https://doi.org/10.1016/j.chest.2020.09.273
Autor:
Paul B. Fisher, Allen Elster, Aditya Sithamraju, Robert Holladay, Ammar Alqaid, Rishi Arora, David Chambers
Publikováno v:
Chest. 158:A2656
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::61792390c1b34282a03c2d1940864ece
https://doi.org/10.1016/j.chest.2020.09.271
https://doi.org/10.1016/j.chest.2020.09.271
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
American journal of therapeutics. 26(3)
BACKGROUND Neurocardiogenic syncope (NCS) is a common form of syncope. Although selective serotonin reuptake inhibitors and other medications have been used to treat NCS with variable success, there is no consensus regarding a first-line therapy. STU
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df7eb78431b2cdfc4b4734d82cc4a921
https://pubmed.ncbi.nlm.nih.gov/28816725
https://pubmed.ncbi.nlm.nih.gov/28816725